112 related articles for article (PubMed ID: 38518655)
21. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.
Avihingsanon A; Apornpong T; Ramautarsing RA; Ubolyam S; Tangkijvanich P; Ananworanich J; Lange JM; Matthews G; Lewin SR; Ruxrungtham K;
Antivir Ther; 2014; 19(1):41-9. PubMed ID: 23970149
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy.
Perazzo H; Cardoso SW; Yanavich C; Nunes EP; Morata M; Gorni N; da Silva PS; Cardoso C; Almeida C; Luz P; Veloso VG; Grinsztejn B
J Int AIDS Soc; 2018 Nov; 21(11):e25201. PubMed ID: 30394678
[TBL] [Abstract][Full Text] [Related]
23. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study.
Sterling RK; Wahed AS; King WC; Kleiner DE; Khalili M; Sulkowski M; Chung RT; Jain MK; Lisker-Melman M; Wong DK; Ghany MG;
Am J Gastroenterol; 2019 May; 114(5):746-757. PubMed ID: 30410040
[TBL] [Abstract][Full Text] [Related]
25. Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.
Stockdale AJ; Phillips RO; Beloukas A; Appiah LT; Chadwick D; Bhagani S; Bonnett L; Sarfo FS; Dusheiko G; Geretti AM;
Clin Infect Dis; 2015 Sep; 61(6):883-91. PubMed ID: 26021992
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal.
Ramírez Mena A; Ngom NF; Tine J; Ndiaye K; Fortes L; Ndiaye O; Fall M; Gaye A; Ka D; Seydi M; Wandeler G; On Behalf Of The Sen-B Study Group
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893680
[TBL] [Abstract][Full Text] [Related]
27. [Survival analysis on HIV/AIDS cases newly received antiretroviral therapy who coinfected with hepatitis B virus in Jiangsu Province, 2005-2020].
Qiu T; Ding P; Zhang Z; Zhai XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):220-224. PubMed ID: 38413060
[No Abstract] [Full Text] [Related]
28. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
[TBL] [Abstract][Full Text] [Related]
29. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.
Weissmann L; Picone CM; Gouvêa MSG; Ferreira PRA; Viana MSVB; Pinho JRR; Cassenote AJF; Segurado AC
Braz J Infect Dis; 2019; 23(6):441-450. PubMed ID: 31715124
[TBL] [Abstract][Full Text] [Related]
31. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia.
Vinikoor MJ; Mulenga L; Siyunda A; Musukuma K; Chilengi R; Moore CB; Chi BH; Davies MA; Egger M; Wandeler G;
Trop Med Int Health; 2016 Nov; 21(11):1435-1441. PubMed ID: 27499385
[TBL] [Abstract][Full Text] [Related]
32. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
Lincoln D; Petoumenos K; Dore GJ;
HIV Med; 2003 Jul; 4(3):241-9. PubMed ID: 12859323
[TBL] [Abstract][Full Text] [Related]
33. Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4
Kouamé GM; Gabillard D; Moh R; Badje A; Ntakpé JB; Emième A; Maylin S; Toni TD; Ménan H; Zoulim F; Danel C; Anglaret X; Eholié S; Lacombe K; Boyd A
Antivir Ther; 2021; 26(1-2):25-33. PubMed ID: 35485344
[TBL] [Abstract][Full Text] [Related]
34. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy.
Collazos J; Valle-Garay E; Carton JA; Montes AH; Suarez-Zarracina T; De la Fuente B; Asensi V
HIV Med; 2016 Aug; 17(7):532-41. PubMed ID: 26754349
[TBL] [Abstract][Full Text] [Related]
36. Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Matthews GV; Neuhaus J; Bhagani S; Mehta SH; Vlahakis E; Doroana M; Naggie S; Arenas-Pinto A; Peters L; Rockstroh JK;
HIV Med; 2015 Apr; 16 Suppl 1():129-36. PubMed ID: 25711331
[TBL] [Abstract][Full Text] [Related]
37. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.
Martin NK; Devine A; Eaton JW; Miners A; Hallett TB; Foster GR; Dore GJ; Easterbrook PJ; Legood R; Vickerman P
AIDS; 2014 Jan; 28 Suppl 1():S35-46. PubMed ID: 24468945
[TBL] [Abstract][Full Text] [Related]
38. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.
Marchetti G; Cozzi-Lepri A; Tincati C; Calcagno A; Ceccherini-Silberstein F; De Luca A; Antinori A; Castagna A; Puoti M; Monforte Ad;
BMC Infect Dis; 2014 Feb; 14():79. PubMed ID: 24520976
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS;
J Acquir Immune Defic Syndr; 2020 Dec; 85(5):e81-e89. PubMed ID: 32842055
[TBL] [Abstract][Full Text] [Related]
40. Liver fibrosis after antiretroviral therapy in a longitudinal cohort of sexually infected HIV patients in eastern China.
Wei Q; Lin H; Ding Y; Liu X; Wu Q; Shen W; Gao M; He N
Biosci Trends; 2017 Jul; 11(3):274-281. PubMed ID: 28484111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]